Navigation Links
Cephalon Net Sales Increase 9% and Net Cash from Operations Surpasses $200 Million in the Third Quarter 2009
Date:10/27/2009

ica, Inc. ($27.2M). (4) To exclude costs related to the CIMA restructuring. (5) To exclude charges related to the settlement of investigations by the Offices of the Attorney General of Connecticut and Massachusetts and estimated relator attorney fees. (6) To exclude non-cash interest expense associated with our convertible debt ($40.5M in 2009; $36.3M in 2008) and accrued interest related to the agreement in principle reached with the U.S. Attorney's Office in Philadelphia ($11.3M in 2008). (7) In 2009, to exclude the following gains and losses related to the acquisition of Arana Therapeutics Limited: - $6.6M gain on pre-bid Arana holdings; - $2.8M loss on contingent consideration (90% ownership incentive payment); - $10.0M gain on the excess of net assets over consideration; - $19.0M gains on foreign exchange derivative instruments; - $5.6M foreign exchange gain on Australian Dollar acquisition funds; and - $1.6M dividend income related to our initial purchase of Arana shares. (8) To exclude charges related to the deconsolidation of Acusphere ($9.3M), the acquisition of worldwide license rights related to LUPUZOR from ImmuPharma ($30.0M), license rights for bendamustine hydrochloride in China and Hong Kong ($0.8M) and license rights to certain of XOMA Ltd.'s proprietary antibody library materials ($6.0M) in 2009 and the license of Acusphere HDDS technology for use in oncology therapeutics in 2008. (9) In 2009 to exclude the portion of non-cash charges related to our acquisition of Arana Therapeutics Limited that are reflected in adjustments (7) above but do not affect net income because they are attributed to noncontrolling interests. (10) To reflect the tax effect of pre-tax adjustments at applicable tax rates and certain other tax adjustments primarily related to the tax benefits for the settlement
'/>"/>
SOURCE Cephalon, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non-Hodgkins Lymphoma
3. Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkins Lymphoma
4. Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain
5. Cephalon Signs Option Agreement to Acquire Ception Therapeutics
6. Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression
7. Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder
8. Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
9. Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder
10. Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associated with Jet Lag Disorder
11. Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... and ORANGEBURG, N.Y., March 30, 2015  Uroplasty, ... VSCI ) shareholders have voted at the ... to approve the previously announced agreement and plan ... "We are pleased with the outcome of today,s ... both shareholder groups for approving the merger agreement," ...
(Date:3/30/2015)... -- Rigrodsky & Long, P.A.: , Do you own ... , Did you purchase any of your shares prior ... proposed buyout price is too low? , Do you ... & Long, P.A. announces that it is investigating potential ... Inc. ("Auspex" or the "Company") (NASDAQ GM: ASPX ) ...
(Date:3/30/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/n6x9q9/marine ) ... Biotechnology - Global Strategic Business Report" report ... forecasts are provided for the period 2013 through ... for these markets. Market data and analytics are ... This report analyzes the worldwide markets for Marine ...
Breaking Medicine Technology:Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 2Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 3Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 4AUSPEX PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 2Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 2Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 3Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 4Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 5Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 6Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 7
... airway bypass procedure to treat,advanced widespread emphysema, ... Lung Associates and the Chicago Chest Center recently ... for Emphysema) Trial to explore,an investigational treatment for ... a minimally invasive bronchoscopic procedure,designed to help patients ...
... ImQuest BioSciences, Inc.,announced today the publication of ... to investigate the efficacy and toxicity of a,series ... manuscript,published in the journal Antiviral Chemistry and Chemotherapy, ... based on compounds which,it licensed from Samjin Pharmaceutical ...
Cached Medicine Technology:Hope for Emphysema Sufferers: Clinical Trial That May Help Patients Breathe Easier Begins at Central DuPage Hospital 2Hope for Emphysema Sufferers: Clinical Trial That May Help Patients Breathe Easier Begins at Central DuPage Hospital 3Hope for Emphysema Sufferers: Clinical Trial That May Help Patients Breathe Easier Begins at Central DuPage Hospital 4ImQuest Publishes Results of Important Structure Activity Relationship Program on Dual Acting Pyrimidinediones 2
(Date:3/31/2015)... 31, 2015 A new study by Health ... U.S. rank employee turnover as their greatest staffing concern this ... half the battle – once you have them, you need ... new trends in healthcare recruiting blog series , which ... , Turnover in hospitals has high numbers and results in ...
(Date:3/31/2015)... Wisconsin (PRWEB) March 31, 2015 The legendary ... 5 to October 2 in North America, and dates for ... areas. The group will perform many great hits during upcoming ... for March 30 on Hollywood Boulevard that will air on ... television appearance in the U.S. featuring David Lee Roth. , ...
(Date:3/30/2015)... 2015 A new legal resource ... family members who may have been prescribed Zofran, or ... sickness. The site was created in response to the ... C.A. No. 11-10398-RWZ, filed with the United States District ... reports that this case alleged that GlaxoSmithKline gave doctors ...
(Date:3/30/2015)... March 31, 2015 NAPW ... Operator for Diamond Pharmacy Services, as a 2015 ... recognized with this prestigious distinction for leadership in ... professional women in the country, spanning virtually every ... Women is a powerfully vibrant networking community with ...
(Date:3/30/2015)... NAPW honors Rachel L. ... Hearts, as a 2015 Professional Woman of the Year. ... in home health services. As the largest, most-recognized organization ... and profession, the National Association of Professional Women (NAPW) ... members and over 200 Local Chapters. , “I've quadrupled ...
Breaking Medicine News(10 mins):Health News:New Survey Finds Staff Turnover Top Concern for Healthcare Recruiters in 2015 2Health News:New Survey Finds Staff Turnover Top Concern for Healthcare Recruiters in 2015 3Health News:New Survey Finds Staff Turnover Top Concern for Healthcare Recruiters in 2015 4Health News:Van Halen Presale Tickets: QueenBeeTickets.com Kicks Off Van Halen Ticket Sales with Reduced Prices on Seats for the 2015 Concert Tour During This Week's Presales 2Health News:Robert Gardner Law Announces Resource Site for Patients Prescribed Zofran During Pregnancy 2Health News:National Association of Professional Women Announces Tamara Mitchell, Owner / Operator of Diamond Pharmacy Services, a 2015 Professional Woman of the Year 2Health News:National Association of Professional Women Announces Rachel L. Gregus, Manager / Co-Founder of Safe Hands Warm Hearts, a 2015 Professional Woman of the Year 2
... The world,s first radar breast imaging system developed at ... scanned for breast cancer, is being trialled at North ... Dr Ian Craddock from the University of Bristol have ... a breast-imaging device which uses radio waves and therefore ...
... 100 HONOREES, COLLEGE STATION, Texas, Nov. 11 ... the 4th annual "Aggie 100",list of the fastest-growing ... students. Clarus Imaging Center of Houston, Oprex Surgery,Center ... among the firms,selected for the award. The program ...
... Nov. 11 Hydron,Technologies, Inc. (OTC Bulletin Board: ... agreement with Brand Builders International, LLC, a private,marketing ... Builders Rx, LLC., Hydron Technologies has been ... Hydron introduced the only non-occlusive,polymer that binds moisture ...
... greater control and,security, SPRINGFIELD, Mass., Nov. ... of whole life insurance products, Massachusetts Mutual ... of updated,versions of three products and riders ... To view the Multimedia News Release, ...
... 5 years of standard shots under skin, study finds ... study appears to point the way toward a faster, ... by using direct injections into the lymph node. , ... and involving dozens of injections, the new method appears ...
... silver -- and healthy -- lining to the miserable ... just may help prevent cancer -- particularly colon, skin, ... tract cancer, according to a new Cornell study. , ... the external environment," said Paul Sherman, Cornell professor of ...
Cached Medicine News:Health News:New technology could revolutionize breast cancer screening 2Health News:New technology could revolutionize breast cancer screening 3Health News:Altus Healthcare Management Systems' Oprex Surgery Center, Clarus Imaging Center & Zerenity Sleep Lab of Houston 2Health News:Hydron Technologies, Inc. and Brand Builders International, LLC Join Forces to Form New Entity 2Health News:Hydron Technologies, Inc. and Brand Builders International, LLC Join Forces to Form New Entity 3Health News:Video: MassMutual Enhances Whole Life Insurance Products - Provides Flexibility, Guarantees 2Health News:Video: MassMutual Enhances Whole Life Insurance Products - Provides Flexibility, Guarantees 3Health News:Lymph Node Shots Tested for Grass Pollen Allergy 2Health News:Lymph Node Shots Tested for Grass Pollen Allergy 3Health News:The miseries of allergies just may help prevent some cancers, study finds 2Health News:The miseries of allergies just may help prevent some cancers, study finds 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: